Understanding ASB16: A Potential Drug Target and Biomarker (G92591)

Target Name: ASB16

NCBI ID: G92591

ASB16

Understanding ASB16: A Potential Drug Target and Biomarker

ASB16, also known asankyrin repeat and SOCS box containing 16, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and presence in various biological processes make it an attractive candidate for further research.

ASB16 is a small RNA molecule that consists of 16 amino acid residues. It is highly conserved, with similar sequences found in various organisms, including humans. The molecule has a unique feature that consists of a long terminal extension, also known as an N-terminal hypervariable region (HVR), which is rich in conserved putative transmembrane domains (TMDs) and other potential interaction partners.

One of the most interesting features of ASB16 is its ability to interact with various protein partners, including known drug targets. This interaction has led to the suggestion that ASB16 may serve as a biomarker or drug target. The N-terminal HVR of ASB16 contains a putative N-terminal transmembrane domain (TMD), which is known to be involved in various cellular processes, including cell signaling, protein-protein interactions, and intracellular signaling.

ASB16's ability to interact with known drug targets has led to its potential as a drug target. One of the most promising drug targets associated with ASB16 is the protein known as TrkA, which is a key regulator of the neurotransmitter dopamine. TrkA has been shown to interact with ASB16 and has been proposed as a potential drug target for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

In addition to its potential as a drug target, ASB16 has also been shown to play a role in various biological processes. For example, it has been shown to be involved in cell signaling pathways that are involved in cell growth, differentiation, and the regulation of cellular processes. It has also been shown to play a role in the regulation of gene expression and has been shown to interact with various proteins that are involved in cellular signaling.

ASB16's unique structure and its interaction with various protein partners make it an attractive candidate for further research. Further studies are needed to determine the exact function of ASB16 and its potential as a drug target.

In conclusion, ASB16 is a non-coding RNA molecule that has unique structure and has been shown to interact with various protein partners. Its potential as a drug target and its involvement in various biological processes make it an attractive candidate for further research. Further studies are needed to fully understand its function and its potential as a drug.

Protein Name: Ankyrin Repeat And SOCS Box Containing 16

Functions: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins

The "ASB16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASB16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets